Available IPD datapackage for study 'A Phase 2, Multicenter, Open-Label, Extension Study to Evaluate the Long-Term Safety, Clinical Activity, and Pharmacokinetics of ALN-TTR02 in Patients With Familial Amyloidotic Polyneuropathy Who Have Previously Received ALN-TTR02'

Name: Available IPD datapackage for study 'A Phase 2, Multicenter, Open-Label, Extension Study to Evaluate the Long-Term Safety, Clinical Activity, and Pharmacokinetics of ALN-TTR02 in Patients With Familial Amyloidotic Polyneuropathy Who Have Previously Received ALN-TTR02'
Creator: Vivli
Published: 2026-03-05 03:14:49
License: 暂无描述

DataCite Commons2026-03-05 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/dataPackages/PR00008231.0

下载链接

链接失效反馈

官方服务：

资源简介：

The purpose of this study is to evaluate the safety and tolerability of long-term dosing with ALN-TTR02 (patisiran) in patients with transthyretin (TTR) mediated amyloidosis (ATTR).

提供机构：

Vivli

创建时间：

2026-03-05